At the start of 2020 the government announced that coverage was changing for people who take Remicade® (infliximab) for the treatment of Crohn’s disease or ulcerative […]

[iframe_loader type=’iframe’ width=’100%’ height=’600′ frameborder=’0′ scrolling=’no’ src=’/wp-content/uploads/articulate_uploads/IBD-Benefits-and-Risk-Assesment-Tool/story.html’] Making informed decisions is imperative to your good health but understanding the benefits and risks associated with IBD therapy […]